Search

Your search keyword '"Hooper DK"' showing total 47 results

Search Constraints

Start Over You searched for: Author "Hooper DK" Remove constraint Author: "Hooper DK"
47 results on '"Hooper DK"'

Search Results

1. Pediatric Learning Health Networks in Solid Organ Transplantation-Engaging all Stakeholders to Achieve Health for Children Who Require Transplantation.

2. Treatment of a patient with inoperable tumoral calcinosis associated with end stage kidney disease: A case report.

3. Carfilzomib-based antibody mediated rejection therapy in pediatric kidney transplant recipients.

4. Tacrolimus pharmacokinetics are influenced by CYP3A5, age, and concomitant fluconazole in pediatric kidney transplant patients.

5. The Barriers Assessment Tool-A Patient-Centered Measure of Adherence Barriers in Pediatric Kidney Transplantation.

6. Model-Informed Estimation of Acutely Decreased Tacrolimus Clearance and Subsequent Dose Individualization in a Pediatric Renal Transplant Patient With Posterior Reversible Encephalopathy Syndrome.

7. A randomized controlled trial of preemptive rituximab to prevent recurrent focal segmental glomerulosclerosis post-kidney transplant (PRI-VENT FSGS): protocol and study design.

8. Donor specific antibody surveillance among pediatric kidney transplant programs: A report from the improving renal outcome collaborative.

9. COVID-19 in pediatric kidney transplantation: a follow-up report of the Improving Renal Outcomes Collaborative.

10. The learning health system for pediatric nephrology: building better systems to improve health.

11. Heart-kidney listing is better than isolated heart listing for pediatric heart transplant candidates with significant renal insufficiency.

12. A Cost-effectiveness Analysis of Adherence Promotion Strategies to Improve Rejection Rates in Adolescent Kidney Transplant Recipients.

13. Kidney transplantation in pediatric patients with rheumatologic disorders.

14. A Medication Adherence Promotion System to Reduce Late Kidney Allograft Rejection: A Quality Improvement Study.

15. Primary hyperoxaluria diagnosed after kidney transplant: A review of the literature and case report of aggressive renal replacement therapy and lumasiran to prevent allograft loss.

16. Re-transplantation in pediatric patients with failure of primary transplant due to recurrent focal segmental glomerulosclerosis: A pediatric nephrology research consortium study.

17. Predicting acute rejection in children, adolescents, and young adults with a kidney transplant by assessing barriers to taking medication.

18. COVID-19 in pediatric kidney transplantation: The Improving Renal Outcomes Collaborative.

19. Blood transfusion rates in Baby NINJA (Nephrotoxic Injury Negated by Just-in-Time Action)-a single-center experience.

20. Multicenter data to improve health for pediatric renal transplant recipients in North America: Complementary approaches of NAPRTCS and IROC.

21. Clinical Outcomes of Allogeneic Ocular Surface Stem Cell Transplantation in Pediatric Patients.

22. The Improving Renal Outcomes Collaborative: Blood Pressure Measurement in Transplant Recipients.

23. Implementing a Process to Systematically Identify and Address Poor Medication Adherence in Pediatric Liver Transplant Recipients.

24. LDL-apheresis-induced remission of focal segmental glomerulosclerosis recurrence in pediatric renal transplant recipients.

25. Quality initiatives in pediatric transplantation.

26. Composite Health Outcomes in Pediatric and Young Adult Kidney Transplant Recipients.

27. IGG3 anti-HLA donor-specific antibodies and graft function in pediatric kidney transplant recipients.

28. Predicting Health Care Utilization and Charges Using a Risk Score for Poor Adherence in Pediatric Kidney Transplant Recipients.

29. Durability of the hepatitis B vaccination in pediatric renal transplant recipients.

30. Mycophenolate mofetil-related leukopenia in children and young adults following kidney transplantation: Influence of genes and drugs.

31. Assessing barriers to adherence in routine clinical care for pediatric kidney transplant patients.

32. Ambulatory Blood Pressure Control in Children and Young Adults After Kidney Transplantation.

33. TFE3-positive renal cell carcinoma occurring in three children with dysfunctional kidneys on immunosuppression.

34. Ambulatory Blood Pressure, Left Ventricular Hypertrophy, and Allograft Function in Children and Young Adults After Kidney Transplantation.

35. Masked hypertension and allograft function in pediatric and young adults kidney transplant recipients.

36. A systems-based approach to managing blood pressure in children following kidney transplantation.

37. Clinical Practice of Steroid Avoidance in Pediatric Kidney Transplantation.

38. Prevalence and predictors of aortic dilation as a novel cardiovascular complication in children with end-stage renal disease.

39. Population pharmacokinetic-pharmacodynamic modelling of mycophenolic acid in paediatric renal transplant recipients in the early post-transplant period.

40. The quality of cardiovascular disease care for adolescents with kidney disease: a Midwest Pediatric Nephrology Consortium study.

41. Reliable individualized monitoring improves cholesterol control in kidney transplant recipients.

42. Risk of tacrolimus toxicity in CYP3A5 nonexpressors treated with intravenous nicardipine after kidney transplantation.

43. Characteristics of successful recruitment in prospective pediatric pharmacogenetic studies.

44. Interaction between tacrolimus and intravenous nicardipine in the treatment of post-kidney transplant hypertension at pediatric hospitals.

45. The influence of context on quality improvement success in health care: a systematic review of the literature.

46. Panel-reactive antibodies late after allograft implantation in children.

47. Identification of genes that are regulated transcriptionally by Myc in childhood tumors.

Catalog

Books, media, physical & digital resources